CDK2-IN-52
CDK2-IN-52 (Compound Cpb No 39) is a selective cyclin-dependent kinase 2 (CDK2) inhibitor with a DC50 value of 1-10 nM. CDK2-IN-52 induces cell cycle arrest and suppresses tumor cell proliferation. CDK2-IN-52 is promising for research of CDK2-overexpressing malignancies such as breast and ovarian cancers[1].
Product Specifications
CAS Number
3038638-82-0
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C1NC(CCN1C2=NN(C)C3=C2C=CC(C4CCN(CC5CCN(CC5)C6=CC=CC(S(=O)(N7CCC(CC7)NC8=NC=C(C=N8)Cl)=O)=C6)CC4)=C3)=O
Molecular Formula
C38H47ClN10O4S
Molecular Weight
775.36
References & Citations
[1]Zhiyong Yu, et al. Bifunctional compounds containing 2,5-substituted pyrimidine derivatives for degrading cyclin-dependent kinase 2 via ubiquitin proteasome pathway. WO2024102849A1. 2024-05-16.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
14228151 3x 1.0 µg DNA
C1orf87 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
